Patents by Inventor Garrit Koller

Garrit Koller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220313152
    Abstract: The present invention provides non-invasive intraoral devices and methods for the detection of intraoral acid exposure, methods of making said devices, and their use in the diagnosis of disorders such as gastro-oesophageal reflux disease (GORD).
    Type: Application
    Filed: September 11, 2020
    Publication date: October 6, 2022
    Inventors: Garrit KOLLER, Saoirse O'TOOLE, Timothy WATSON, Francesco MANOCCI, David BARTLETT
  • Patent number: 10472393
    Abstract: The invention relates to a method for inhibiting an ADAM protease, comprising inhibiting binding to an integrin-binding loop of a disintegrin domain in the ADAM protease. Also provided are cyclic peptides which inhibit binding to an integrin-binding loop of an ADAM protease, as well as associated pharmaceutical compositions, uses and methods of treatment.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: November 12, 2019
    Assignees: CANCER RESEARCH TECHNOLOGY LIMITED, KING'S COLLEGE LONDON
    Inventors: Joerg Bartsch, Garrit Koller
  • Publication number: 20170107258
    Abstract: The invention relates to a method for inhibiting an ADAM protease, comprising inhibiting binding to an integrin-binding loop of a disintegrin domain in the ADAM protease. Also provided are cyclic peptides which inhibit binding to an integrin-binding loop of an ADAM protease, as well as associated pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: December 8, 2016
    Publication date: April 20, 2017
    Inventors: Joerg Bartsch, Garrit Koller
  • Patent number: 9611500
    Abstract: A method and apparatus for detecting the presence of the viable cells in an endodontic sample in or taken from an endodontic cavity in the tooth, such as the root canal, enables the rapid and low cost identification of the presence or absence of bacteria or other viable cell tissue in the endodontic space by first incubating a viable cell indicator with an endodontic sample for a pre-determined period suitable for chair-side test and then measuring and/or detecting a change in a parameter (e.g. fluorescence) associated with the viable cell indicator. Thereby, the required level of root canal treatment can be reached which minimizes the risk of re-infection without the time, cost and potentially harm of over-preparation and over treatment by the dental surgeon or of a re-treatment.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: April 4, 2017
    Assignee: KINGS COLLEGE LONDON
    Inventors: Richard Cook, Garrit Koller, Timothy Watson, Federico Foschi, Francesco Mannocci, Frederic Festy
  • Patent number: 9546198
    Abstract: The invention relates to a method for inhibiting an ADAM protease, comprising inhibiting binding to an integrin-binding loop of a disintegrin domain in the ADAM protease. Also provided are cyclic peptides which inhibit binding to an integrin-binding loop of an ADAM protease, as well as associated pharmaceutical compositions, uses and methods of treatment.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: January 17, 2017
    Assignee: CANCER RESEARCH TECHNOLOGY LIMITED
    Inventors: Joerg Bartsch, Garrit Koller
  • Publication number: 20160168202
    Abstract: The invention relates to a method for inhibiting an ADAM protease, comprising inhibiting binding to an integrin-binding loop of a disintegrin domain in the ADAM protease. Also provided are cyclic peptides which inhibit binding to an integrin-binding loop of an ADAM protease, as well as associated pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: July 14, 2015
    Publication date: June 16, 2016
    Inventors: Joerg Bartsch, Garrit Koller
  • Publication number: 20140308694
    Abstract: A method and apparatus for detecting the presence of the viable cells in an endodontic sample in or taken from an endodontic cavity in the tooth, such as the root canal, enables the rapid and low cost identification of the presence or absence of bacteria or other viable cell tissue in the endodontic space by first incubating a viable cell indicator with an endodontic sample for a pre-determined period suitable for chair-side test and then measuring and/or detecting a change in a parameter (e.g. fluorescence) associated with the viable cell indicator. Thereby, the required level of root canal treatment can be reached which minimizes the risk of re-infection without the time, cost and potentially harm of over-preparation and over treatment by the dental surgeon or of a re-treatment.
    Type: Application
    Filed: August 14, 2012
    Publication date: October 16, 2014
    Applicant: KINGS COLLEGE LONDON
    Inventors: Richard Cook, Garrit Koller, Timothy Watson, Federico Foschi, Francesco Mannocci, Frederic Festy
  • Publication number: 20100291063
    Abstract: The invention relates to a method for inhibiting an adam protease, comprising inhibiting binding to an integrin-binding loop of a disintegrin domain in the adam protease. Also provided are cyclic peptides which inhibit binding to an integrin-binding loop of an adam protease, as well as associated pharmaceutical compositions, uses and methods of treatment.
    Type: Application
    Filed: October 10, 2008
    Publication date: November 18, 2010
    Applicant: Kings College London
    Inventors: Joerg Bartsch, Garrit Koller
  • Patent number: D685529
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: July 2, 2013
    Assignee: King's College London
    Inventors: Garrit Koller, Richard Cook, Timothy Watson